Why Diabetes Still Needs a New Solution

Diabetes is one of the most widespread chronic conditions in the world today, affecting over 537 million people globally, yet the way we treat it has not fundamentally changed in decades. For people living with insulin-dependent diabetes, daily life is still shaped by repeated injections, constant monitoring, and the ongoing mental load of calculating and managing blood glucose levels. Even with advances like continuous glucose monitors and insulin pumps, treatment still depends on external systems and frequent user intervention rather than something that works seamlessly with the body itself.

What makes this particularly challenging is that insulin therapy is not just about delivering the right dose, but delivering it at the right moment, in response to a constantly changing physiological environment. Despite major scientific progress, there is still no widely available system that can autonomously respond to glucose levels inside the body in a truly self-regulating way. That gap between biological need and technological capability is what Dhereputics is working to address